[holding answer 27 March 2007]: The National Institute for Health and Clinical Excellence (NICE), published a technical appraisal on naltrexone as a treatment for relapse prevention on 24 January 2007.
The National Treatment Agency (NTA) is supporting the Department in developing an implementation strategy for the dissemination of the NICE technology appraisal on naltrexone and their other current work relating to drug treatment. This strategy will seek to ensure that complementary initiatives undertaken by NICE and the NTA are disseminated in a coherent and co-ordinated way to inform the commissioners and providers of drug treatment.